Apollo Hospitals Enterprise Ltd vs Dr Lalchandani Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Apollo Hospitals Enterprise Ltd is ₹ 7731 as of 23 Oct 15:30 . The P/E Ratio of Apollo Hospitals Enterprise Ltd changed from 277.5 on March 2021 to 55 on March 2026 . This represents a CAGR of -23.64% over 6 yearsThe P/E Ratio of Dr Lalchandani Labs Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Apollo Hospitals Enterprise Ltd changed from ₹ 41739 crore on March 2021 to ₹ 106808 crore on March 2026 . This represents a CAGR of 16.95% over 6 yearsThe Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Apollo Hospitals Enterprise Ltd for the Jun '26 is ₹ 7105 crore as compare to the Mar '26 revenue of ₹ 6659 crore. This represent the growth of 6.7% The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Apollo Hospitals Enterprise Ltd for the Jun '26 is ₹ 1154 crore as compare to the Mar '26 ebitda of ₹ 1065 crore. This represent the growth of 8.38% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Apollo Hospitals Enterprise Ltd changed from ₹ 315.5 crore to ₹ 610.4 crore over 9 quarters. This represents a CAGR of 34.09% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Apollo Hospitals Enterprise Ltd changed from 41.09 % on March 2021 to 19.27 % on March 2026 . This represents a CAGR of -11.86% over 6 yearsThe Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Limited (AHEL) is a leading private sector healthcare provider in Asia.
It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics.
AHEL's Hospitals are situated in Chennai, Hyderabad, Delhi, Ahmedabad, Pune, Chenganur, Coimbatore, Jaipur, Madurai, Anantpur, Nellore, Kurnool, Bhopal, Ranchi, Bilaspur and Bacheli.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis and providing / selling high quality pharma and wellness products through a network of pharmacies.
The principal activities of the Company include operation of multidisciplinary private hospitals, clinics and pharmacies. Apollo Hospitals Enterprise Limited was incorporated as a Public Limited Company on December 5, 1979, a comprehensive 250-bed hospital with an emphasis on speciality and super specialties in over fifty departments at Chennai.

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

FAQs for the comparison of Apollo Hospitals Enterprise Ltd and Dr Lalchandani Labs Ltd

Which company has a larger market capitalization, Apollo Hospitals Enterprise Ltd or Dr Lalchandani Labs Ltd?

Market cap of Apollo Hospitals Enterprise Ltd is 111,173 Cr while Market cap of Dr Lalchandani Labs Ltd is 6 Cr

What are the key factors driving the stock performance of Apollo Hospitals Enterprise Ltd and Dr Lalchandani Labs Ltd?

The stock performance of Apollo Hospitals Enterprise Ltd and Dr Lalchandani Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Apollo Hospitals Enterprise Ltd and Dr Lalchandani Labs Ltd?

As of October 25, 2026, the Apollo Hospitals Enterprise Ltd stock price is INR ₹7731.95. On the other hand, Dr Lalchandani Labs Ltd stock price is INR ₹6.96.

How do dividend payouts of Apollo Hospitals Enterprise Ltd and Dr Lalchandani Labs Ltd compare?

To compare the dividend payouts of Apollo Hospitals Enterprise Ltd and Dr Lalchandani Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.